Litcius/Paper detail

Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial

Eric J. Sherman, Jonathan Harris, Keith C. Bible, Ping Xia, Ronald Ghossein, Christine H. Chung, Nadeem Riaz, G. Brandon Gunn, Robert L. Foote, Sue S. Yom, Stuart J. Wong, Shlomo A. Koyfman, Michael Dzeda, David A. Clump, Saad A. Khan, Manisha H. Shah, Kevin P. Redmond, Pedro A. Torres‐Saavedra, Quynh‐Thu Le, Nancy Y. Lee

2023The Lancet Oncology39 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePazopanibInternal medicineAnaplastic thyroid cancerPlaceboClinical endpointOncologyPopulationRadiation therapyClinical trialThyroid cancerCancerPathologyEnvironmental healthSunitinibAlternative medicineThyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid SurgeryMultiple and Secondary Primary Cancers